Education
About Us
Working with TipRanks
Follow Us
Aspira Women's Health (AWHL)
OTHER OTC:AWHL
AWHL Stock Chart & Stats
$0.49
--
Market closed
$0.49
--
Day’s Range― - ―
52-Week Range$0.02 - $1.38
Previous CloseN/A
VolumeN/A
Average Volume (3M)100.39K
Market Cap
$20.89M
Enterprise Value$6.46M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.70
Next Earnings
Nov 13, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.07
Shares Outstanding42,655,920
10 Day Avg. Volume120,018
30 Day Avg. Volume100,391
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.31
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
Aspira Women's Health News
AWHL FAQ
What was Aspira Women's Health’s price range in the past 12 months?
Aspira Women's Health lowest stock price was $0.02 and its highest was $1.38 in the past 12 months.
What is Aspira Women's Health’s market cap?
Aspira Women's Health’s market cap is $20.89M.
When is Aspira Women's Health’s upcoming earnings report date?
Aspira Women's Health’s upcoming earnings report date is Nov 13, 2025 which is in 14 days.
How were Aspira Women's Health’s earnings last quarter?
Aspira Women's Health released its earnings results on Aug 13, 2025. The company reported -$0.07 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.07.
Is Aspira Women's Health overvalued?
According to Wall Street analysts Aspira Women's Health’s price is currently Overvalued.
Does Aspira Women's Health pay dividends?
Aspira Women's Health does not currently pay dividends.
What is Aspira Women's Health’s EPS estimate?
Aspira Women's Health’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Aspira Women's Health have?
Aspira Women's Health has 42,655,920 shares outstanding.
What happened to Aspira Women's Health’s price movement after its last earnings report?
Aspira Women's Health reported an EPS of -$0.07 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 4.545%.
Which hedge fund is a major shareholder of Aspira Women's Health?
Currently, no hedge funds are holding shares in AWHL
Company Description
Aspira Women's Health
Aspira Women's Health (AWHL) is a healthcare company focused on improving women's health through innovative diagnostic solutions. The company specializes in developing and commercializing advanced tests that aid in the early detection of ovarian cancer and other gynecologic conditions. AWHL's core products include the Ova1 and Overa tests, which utilize a proprietary algorithm to assess the risk of malignancy in adnexal masses, providing valuable information for healthcare providers and patients. By combining scientific expertise with a commitment to women's health, Aspira aims to enhance patient outcomes and empower women in their healthcare journeys.
Technical Analysis
Ownership Overview
13.44% Insiders
0.26% Mutual Funds
0.25% Other Institutional Investors
86.31% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---